Select your country

Websites worldwide

Select a country to go to the website of the respective STADA sales company.

Belarus (1)

Belgium (1)

Bosnia-Herzegovina (1)

Bulgaria (1)

Croatia (1)

Denmark (1)

Hungary (1)

Italy (1)

Montenegro (1)

Portugal (1)

Romania (1)

Saudi Arabia (1)

Serbia (1)

Slovenia (1)

Switzerland (1)

The Phillippines (1)

United Arab Emirates (1)

People living with immune-mediated diseases such as rheumatoid disorders, inflammatory bowel disease or skin conditions can be affected for the rest of their lives. For example, the chronic immune-mediated skin disease psoriasis affects at least 100 million people worldwide1, and approximately 0.2% of Europe’s population live with inflammatory bowel diseases2.

By offering an expanding range of biosimilars in Europe to treat autoimmune disorders which treat autoimmune disorders, STADA aims to improve patient access to life-altering medicines.